top of page
Search

KIMS Pioneers Use of AR, AI in Brain Tumour Surgery

  • Writer: 효석 이
    효석 이
  • May 22, 2024
  • 2 min read

Updated: May 2


Hyderabad: Brain tumour surgeries are complex procedures and human errors remain a cause of concern. To address this challenge, doctors at the KIMS Hospital, Secunderabad, have incorporated augmented reality (AR) and artificial intelligence (AI) into neurosurgery.


At a press conference, it was stated that Dr Manas Panigrahi, head of neurosurgery, KIMS Hospital, Secunderabad, had successfully performed 16 surgeries using a cutting-edge device developed by Korean firm, SKIA AR, combined with AI. “This marks a first in India and globally of utilising this technology for brain surgery,” Dr Panigrahi said.


In the past, brain tumour surgeries relied on complex preoperative planning and intraoperative navigation systems. This also meant higher cost of procedure and anaesthesia doses. However, SKIA's non-invasive, markerless solution enhances precision and is not expensive, doctors said.


SKIA generates a 3D digital replica of the patient's brain from CT scans, leveraging AI algorithms to overlay this digital twin onto the patient's anatomy in real-time. This approach provides surgeons helpful insights which helps them in precise surgical planning and execution, besides improving patient safety and outcomes.


Tim Kim, chief marketing officer at SKIA Korea, acknowledged Dr Panigrahi's pivotal role in adopting this technology for surgical procedures. “Dr Manas understood the technology and the impact of its application on the outcomes both for the surgeons and the patients,” Tim said.


“His team expanded upon the basic projection, adding critical details wherever necessary in collaboration with the SKIA team leading to significant technological advancement of the device making it attuned to the requirements of surgeons,” he said.


Dr Panigrahi, recognising the need for statistically significant proof of success for the adoption of the technology, conducted 15 procedures to assess SKIA's accuracy and efficacy. "We proposed conducting 15 navigated procedures considered the gold standard number to compare accuracy, and none of the patients experienced complications. Moreover, all our residents quickly mastered the techniques.”


Deccan Chronicle, Reshmi AR, 2024-04-14

 
 
 

Recent Posts

See All

Comentarios


SKIA LOGO WHITE

Solutions

Company

Contact

EMAIL
LINKEDIN
YOUTUBE

SKIA Head, Breast, and Forensics solutions are under development and not commercially available at this time. 

 

​​SKIA Face and Body are currently approved in South Korea, and SKIA OPD is available for sale. Media shown on this website are actual patient cases, but all personal identities have been removed or otherwise anonymized.

SKIA Head and Breast are not yet cleared by the FDA and are not available for sale. Any information about the device, including its potential benefits and risks, is based on preliminary data and should be interpreted accordingly. These devices are not intended for diagnosing, treating, or preventing medical conditions without the supervision of a qualified healthcare professional. SKIA does not guarantee the accuracy or completeness of the information provided and is not liable for any damages arising from the use of the devices or reliance on the information.

©2025 SKIA Inc.

Copyright © 2024 SKIA

bottom of page